Kura Oncology, Inc. (KURA)
12.40
+0.51
(+4.29%)
USD |
NASDAQ |
Aug 24, 16:00
13.48
+1.08
(+8.71%)
After-Hours: 04:33
Kura Oncology Market Cap : 1.103B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.103B |
| August 21, 2026 | 1.058B |
| August 20, 2026 | 1.042B |
| August 19, 2026 | 1.115B |
| August 18, 2026 | 1.097B |
| August 17, 2026 | 1.003B |
| August 14, 2026 | 966.04M |
| August 13, 2026 | 897.55M |
| August 12, 2026 | 884.20M |
| August 11, 2026 | 883.31M |
| August 10, 2026 | 876.20M |
| August 07, 2026 | 849.46M |
| August 06, 2026 | 823.72M |
| August 05, 2026 | 816.62M |
| August 04, 2026 | 840.59M |
| August 03, 2026 | 815.73M |
| July 31, 2026 | 799.75M |
| July 30, 2026 | 826.38M |
| July 29, 2026 | 792.65M |
| July 28, 2026 | 826.38M |
| July 27, 2026 | 900.94M |
| July 24, 2026 | 922.25M |
| July 23, 2026 | 927.57M |
| July 22, 2026 | 935.56M |
| July 21, 2026 | 966.63M |
| Date | Value |
|---|---|
| July 20, 2026 | 947.99M |
| July 17, 2026 | 963.97M |
| July 16, 2026 | 966.63M |
| July 15, 2026 | 1.006B |
| July 14, 2026 | 997.70M |
| July 13, 2026 | 968.40M |
| July 10, 2026 | 1.016B |
| July 09, 2026 | 1.072B |
| July 08, 2026 | 1.076B |
| July 07, 2026 | 1.064B |
| July 06, 2026 | 979.94M |
| July 02, 2026 | 985.27M |
| July 01, 2026 | 956.87M |
| June 30, 2026 | 973.73M |
| June 29, 2026 | 973.73M |
| June 26, 2026 | 967.52M |
| June 25, 2026 | 919.58M |
| June 24, 2026 | 942.66M |
| June 23, 2026 | 921.36M |
| June 22, 2026 | 919.58M |
| June 18, 2026 | 881.42M |
| June 17, 2026 | 849.46M |
| June 16, 2026 | 834.37M |
| June 15, 2026 | 846.80M |
| June 12, 2026 | 803.31M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 102.93M |
| Fortress Biotech, Inc. | 97.60M |
| Syndax Pharmaceuticals, Inc. | 1.745B |
| Spero Therapeutics, Inc. | 70.65M |
| Gossamer Bio, Inc. | 85.55M |
Market Cap Related Metrics
| PS Ratio | 14.18 |
| PEG Ratio | -0.0754 |
| Price to Book Value | 22.78 |
| Price | 12.40 |
| Earnings Yield | -27.11% |
| PEGY Ratio | -0.0754 |